AGRX - Agile Therapeutics EPS misses by $0.02 February, 20 2020 04:25 PM Agile Therapeutics Inc. Agile Therapeutics (NASDAQ:AGRX): Q4 GAAP EPS of -$0.10 misses by $0.02.Cash and equivalents of $34.5M.Shares -14.3%.Press ReleaseMore news on: Agile Therapeutics, Inc., Earnings news and commentary, Healthcare stocks news, ,